Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
Christin Riess, Nina Irmscher, Inken Salewski, et al.
Cancer and Metastasis Reviews (2020) Vol. 40, Iss. 1, pp. 153-171
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest
Wenpeng Zhao, Liang Zhang, Yaya Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
The Renaissance of Cyclin Dependent Kinase Inhibitors
Tobias Ettl, Daniela Schulz, Richard J. Bauer
Cancers (2022) Vol. 14, Iss. 2, pp. 293-293
Open Access | Times Cited: 45
Targeting amino acid metabolism in cancer
Lucie Safrhansova, Kateřina Hložková, Júlia Starková
International review of cell and molecular biology (2022), pp. 37-79
Closed Access | Times Cited: 28
Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activity
Ola Alaa Hamed, Nehad A. El-Sayed, Walaa R. Mahmoud, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107413-107413
Closed Access | Times Cited: 7
Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma
Eman R. Mohammed, Ghada F. Elmasry
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 686-700
Open Access | Times Cited: 26
Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors
Mohammed M. Alanazi, Saleh Aldawas, Nawaf A. Alsaif
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 97-97
Open Access | Times Cited: 15
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
Chara Papalouka, Maria Adamaki, Panagiota Batsaki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2760-2760
Open Access | Times Cited: 15
Dinaciclib Interrupts Cell Cycle and Induces Apoptosis in Oral Squamous Cell Carcinoma: Mechanistic Insights and Therapeutic Potential
Muhammet Oner, Yu-Chiao Cheng, Shiuan-Woei Soong, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2197-2197
Open Access
Glycyrrhizic acid exhibits strong anticancer activity in colorectal cancer cells via SIRT3 inhibition
Zhenkui Zuo, Lulu He, Xiaoyu Duan, et al.
Bioengineered (2021) Vol. 13, Iss. 2, pp. 2720-2731
Open Access | Times Cited: 26
Proteomic Analysis Reveals Trilaciclib-Induced Senescence
Marina Hermosilla-Trespaderne, Mark Xinchen Hu-Yang, Abeer Dannoura, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 6, pp. 100778-100778
Open Access | Times Cited: 3
Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma
Ziyue Gu, Chaoji Shi, Jiayi Li, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications
Rui Sun, Albert H. Kim
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 4, pp. 871-898
Open Access | Times Cited: 15
Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment
Tongchai Payungwong, Krittaya Angkulkrerkkrai, Amphun Chaiboonchoe, et al.
Cancer Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 2
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells
Gabriele Favaretto, Marianna Nicoletta Rossi, Lorenzo Cuollo, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 2
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas
Ernest Duah, Nathan D. Seligson, Avinash K. Persaud, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 8, pp. 1201-1212
Closed Access | Times Cited: 4
Proteomic Analysis Reveals Trilaciclib-Induced Senescence
Marina Hermosilla-Trespaderne, Mark Xinchen Hu-Yang, Abeer Dannoura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer
Ísis de Araújo Ferreira Muniz, Megan Araujo, Jenna Bouassaly, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4009-4009
Open Access | Times Cited: 1
Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging
Chun-Han Huang, Palwasha Khan, Sulan Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6870-6870
Open Access | Times Cited: 1
The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis
Nina Schoenwaelder, Inken Salewski, Nadja Engel, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2396-2396
Open Access | Times Cited: 10
Characterization of Promising Cytotoxic Metabolites from Tabebuia guayacan Hemsl.: Computational Prediction and In Vitro Testing
Seham S. El‐Hawary, Rabab Mohammed, Marwa A. Taher, et al.
Plants (2022) Vol. 11, Iss. 7, pp. 888-888
Open Access | Times Cited: 7
Cyclin-dependent kinase 2 (CDK2)
Ghada F. Elmasry
Elsevier eBooks (2023), pp. 51-62
Closed Access | Times Cited: 2
Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature
Hao Gu, Tingxuan Li, Narasimha M. Beeraka, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0286414-e0286414
Open Access | Times Cited: 2
Identification of Molecular Targets and Potential Mechanisms of Yinchen Wuling San Against Head and Neck Squamous Cell Carcinoma by Network Pharmacology and Molecular Docking
Biyu Zhang, Genyan Liu, Xin Wang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 4
Molecular pathways modulated by phytochemicals in head and neck cancer
Mahesh Kaushik, Ashu Bhan Tiku
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 469-483
Open Access | Times Cited: 4
Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
Morena Fasano, Francesco Perri, Carminia Maria Della Corte, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1045-1045
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top